Structural basis of selective inhibition of human tankyrases

Mohit Narwal, Harikanth Venkannagari, Lari Lehtiö

Research output: Contribution to journalArticlepeer-review

124 Scopus citations


Tankyrases are poly(ADP-ribose) polymerases that have many cellular functions. They play pharmaceutically important roles, at least in telomere homeostasis and Wnt signaling, by covalently ADP-ribosylating target proteins and consequently regulating their functions. These features make tankyrases potential targets for treatment of cancer. We report here crystal structures of human tankyrase 2 catalytic fragment in complex with a byproduct, nicotinamide, and with selective inhibitors of tankyrases (IWR-1) and PARPs 1 and 2 (olaparib). Binding of these inhibitors to tankyrase 2 induces specific conformational changes. The crystal structures explain the selectivity of the inhibitors, reveal the flexibility of a substrate binding loop, and explain existing structure-activity relationship data. The first crystal structure of a PARP enzyme in complex with a potent inhibitor, IWR-1, that does not bind to the widely utilized nicotinamide-binding site makes the structure valuable for development of PARP inhibitors in general.

Original languageEnglish (US)
Pages (from-to)1360-1367
Number of pages8
JournalJournal of medicinal chemistry
Issue number3
StatePublished - Feb 9 2012
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Structural basis of selective inhibition of human tankyrases'. Together they form a unique fingerprint.

Cite this